French Institute of Health and Medical Research-ko ikertzaileekin lankidetzan egindako argitalpenak (62)

2023

  1. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

  2. Type IV Collagen and SOX9 Are Molecular Targets of BET Inhibition in Experimental Glomerulosclerosis

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

2022

  1. 2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19

    Annals of the rheumatic diseases, Vol. 81, Núm. 1, pp. 34-40

  2. Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): Systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs

    RMD Open, Vol. 8, Núm. 2

2021

  1. ATG4D is the main ATG8 delipidating enzyme in mammalian cells and protects against cerebellar neurodegeneration

    Cell Death and Differentiation, Vol. 28, Núm. 9, pp. 2651-2672

  2. Correction to: ATG4D is the main ATG8 delipidating enzyme in mammalian cells and protects against cerebellar neurodegeneration (Cell Death & Differentiation, (2021), 28, 9, (2651-2672), 10.1038/s41418-021-00776-1)

    Cell Death and Differentiation

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  4. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

    Journal of Hepatology, Vol. 74, Núm. 5, pp. 1097-1108

  5. Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis

    Journal of Hepatology, Vol. 75, Núm. 5, pp. 1116-1127

2020

  1. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF

    Journal of Hepatology, Vol. 72, Núm. 4, pp. 688-701

  2. Correction to ‘Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF’ [J Hepatol 2020 (72) 688–701] (Journal of Hepatology (2020) 72(4) (688–701), (S0168827819306968), (10.1016/j.jhep.2019.11.009))

    Journal of Hepatology

  3. Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis

    Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 4, pp. 963-973.e14

  4. Polyphenol intake and differentiated thyroid cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

    International Journal of Cancer, Vol. 146, Núm. 7, pp. 1841-1850

  5. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

    Journal of Hepatology, Vol. 73, Núm. 4, pp. 842-854

2019

  1. Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis

    Gastroenterology, Vol. 157, Núm. 1, pp. 149-162

  2. Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in Cirrhosis

    Hepatology, Vol. 69, Núm. 4, pp. 1686-1701

2018

  1. Aspirin Recapitulates Features of Caloric Restriction

    Cell Reports, Vol. 22, Núm. 9, pp. 2395-2407

  2. Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data

    The Lancet Neurology, Vol. 17, Núm. 10, pp. 895-904

  3. Methionine Restriction Extends Lifespan in Progeroid Mice and Alters Lipid and Bile Acid Metabolism

    Cell Reports, Vol. 24, Núm. 9, pp. 2392-2403

2017

  1. Autophagy couteracts weight gain, lipotoxicity and pancreatic β-cell death upon hypercaloric pro-diabetic regimens

    Cell Death and Disease, Vol. 8, Núm. 8